BioSpace News Archive

ReAlta Life Sciences today announced first-in-human Phase 1 clinical data on RLS-0071, the Company’s complement inhibitor and innate anti-inflammatory product candidate.

Altamira Therapeutics Ltd., a company dedicated to developing therapeutics that address important unmet medical needs, announced it will hold an investor call on Tuesday, April 12, 2022, 8:00 a.m. ET to discuss its full-year 2021 earnings.

PacBio, a leading provider of high-quality, highly accurate sequencing platforms, announced a new collaboration with global agriculture company, Corteva Agriscience, to develop custom, end-to-end workflows for plant, pest and microbial sequencing.

Scilex Holding Company, a nearly 100% majority-owned subsidiary of Sorrento Therapeutics, Inc., a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain, announced an increase of 53% year-over-year preliminary unaudited gross ZTlido sales in March.

Nanoscope Therapeutics , Inc. today announced expansion of its Clinical and Scientific Advisory Board.

Canon Virginia, Inc. (CVI) today announces new relationship with Maxim Biomedical to assemble ClearDetect™ COVID-19 Antigen Home Test Kits.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of an analysis of real-world data that suggest continued treatment of amyotrophic lateral sclerosis (ALS) patients with intravenous (IV) RADICAVA® (edaravone) resulted in a six-month longer median survival, compared to those not treated with the drug.

Paracrine, Inc., announced the online publication of the findings from the STAR I trial in Arthritis & Rheumatology Journal, the official journal of the American College of Rheumatology.

Todos Medical, Ltd. (OTCQB: TOMDF), today announced that its majority-owned subsidiary 3CL Pharma, Ltd. announced that its mechanism-based 3CL protease inhibitors Tollovir® and Tollovid™ that target the active site of the 3CL protease showed robust inhibitory activity against the 3CL protease of the BA.1 and BA.2 strains of the Omicron SARS-CoV-2 variant of concern (VOC).

Albany NY, United States: In case of injury, trauma, or defect in the lower extremities of the body, i.e. the feet and ankles, special plates and screws are available for use to rectify and reconstruct them.